Pharma major, Sun Pharmaceutical Industries has settled its legal tussle with MedImmune over the generic version of Ethyol.
The company, along with its subsidiaries (collectively, Sun Pharma), has executed a settlement agreement with MedImmune, stipulating the dismissal of the lawsuits filed in the US district court for the district of Maryland regarding the submission of an Abbreviated New Drug Application (ANDA) for a generic version of Ethyol.
Read moreSun Pharma resolves litigation with MedImmune over Ethyol